This is in agreement with several studies, demonstrating that NLRP3 activation promoted tumor development in experimental models (41–47) and is associated with susceptibility to melanoma (48) and with poor survival in patients with advanced colorectal cancer (49) or development of various hematologic malignancies (47, 50). This evidence concerns the gene NLRP3 and melanoma.